Efficacy of zinc-carnosine chelate compound, Polaprezinc, enemas in patients with ulcerative colitis
Not Applicable
- Conditions
- lcerative Colitis
- Registration Number
- JPRN-UMIN000008967
- Lead Sponsor
- The Jikei University School of Medicine Division of Gastroenterology and Hepatology
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
Key exclusion criteria: (1) Patients who attend to another clinical trial (2) Patients who is disqualified by physician's assessment (3) Patients who have serious complications (4) Patients who have allergic reaction to Polaprezinc
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The primary end point was a clinical response at week 1.
- Secondary Outcome Measures
Name Time Method Secondary end points were a mucosal healing and a pathological response at week 1.